Suzanne Parry

Suzanne Parry

UNVERIFIED PROFILE

Are you Suzanne Parry?   Register this Author

Register author
Suzanne Parry

Suzanne Parry

Publications by authors named "Suzanne Parry"

Are you Suzanne Parry?   Register this Author

22Publications

500Reads

20Profile Views

ALK Immunohistochemistry in NSCLC: Discordant Staining Can Impact Patient Treatment Regimen.

J Thorac Oncol 2016 12 25;11(12):2241-2247. Epub 2016 Jul 25.

Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2016.07.012DOI Listing
December 2016

Improvement in the quality of molecular analysis of EGFR in non-small-cell lung cancer detected by three rounds of external quality assessment.

J Clin Pathol 2013 Apr 1;66(4):319-25. Epub 2013 Feb 1.

Department of Laboratory Medicine, UK NEQAS for Molecular Genetics, UK NEQAS Edinburgh, The Royal Infirmary of Edinburgh, Edinburgh, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jclinpath-2012-201227DOI Listing
April 2013

Salivary duct carcinomas can be classified into luminal androgen receptor-positive, HER2 and basal-like phenotypes.

Histopathology 2012 Oct;61(4):629-43

Department of Histopathology, Royal Surrey County Hospital, Guildford, SurreyDivision of Clinical Medicine, University of Surrey, Guildford, SurreyDepartment of Histopathology, Royal Devon and Exeter Hospital, Exeter, DevonThe Breakthrough Breast Cancer Research Centre - Institute of Cancer Research, London, UKDepartment of Pathology, Faculty of Medicine, Charles University in Prague, Plzeň, Czech RepublicDepartment of Pathology, Spedali Civili Brescia, Brescia, ItalyDepartment of Histopathology, Imperial College Healthcare Trust, Charing Cross Hospital, LondonDepartment of Oncology, St Lukes Cancer Centre, Royal Surrey County Hospital, Guildford, Surrey, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2559.2012.04252.xDOI Listing
October 2012

Genomic and immunohistochemical analysis of adenosquamous carcinoma of the breast.

Mod Pathol 2010 Jul 7;23(7):951-60. Epub 2010 May 7.

The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/modpathol201082
Publisher Site
http://dx.doi.org/10.1038/modpathol.2010.82DOI Listing
July 2010

Methotrexate induces oxidative DNA damage and is selectively lethal to tumour cells with defects in the DNA mismatch repair gene MSH2.

EMBO Mol Med 2009 Sep;1(6-7):323-37

Cancer Research UK Gene Function and Regulation Group, The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK.

View Article

Download full-text PDF

Source
http://embomolmed.embopress.org/cgi/doi/10.1002/emmm.2009000
Publisher Site
http://dx.doi.org/10.1002/emmm.200900040DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3378145PMC
September 2009

Aberrant expression of E-cadherin in lobular carcinomas of the breast.

Am J Surg Pathol 2008 May;32(5):773-83

Molecular and Cellular Pathology, Mayne Medical School, University of Queensland, Brisbane, Australia.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=00000478-200805000-000
Publisher Site
http://dx.doi.org/10.1097/PAS.0b013e318158d6c5DOI Listing
May 2008

Dynamic expression of Erbb pathway members during early mammary gland morphogenesis.

J Invest Dermatol 2008 Apr 25;128(4):1009-21. Epub 2007 Oct 25.

The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.jid.5701118DOI Listing
April 2008

Neuregulin3 alters cell fate in the epidermis and mammary gland.

BMC Dev Biol 2007 Sep 19;7:105. Epub 2007 Sep 19.

The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research 237 Fulham Road, London SW3 6JB, UK.

View Article

Download full-text PDF

Source
http://bmcdevbiol.biomedcentral.com/articles/10.1186/1471-21
Publisher Site
http://dx.doi.org/10.1186/1471-213X-7-105DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2110892PMC
September 2007

Cytokeratin 5/6 in normal human breast: lack of evidence for a stem cell phenotype.

J Pathol 2004 Oct;204(2):147-52

Breakthrough Toby Robins Breast Cancer Research Centre, Institute of Cancer Research, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.1647DOI Listing
October 2004

Distribution and significance of 14-3-3sigma, a novel myoepithelial marker, in normal, benign, and malignant breast tissue.

J Pathol 2004 Mar;202(3):274-85

The Breakthrough Toby Robins Breast Cancer Research Centre, Institute of Cancer Research, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/path.1530DOI Listing
March 2004

Two distinct HLA-A0201-presented epitopes of the Wilms tumor antigen 1 can function as targets for leukemia-reactive CTL.

Blood 2002 Nov;100(10):3835-7

Department of Immunology, Faculty of Medicine, Imperial College, Hammersmith Hospital, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood.V100.10.3835DOI Listing
November 2002